The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer

SIMPLE SUMMARY: It is estimated that 65% of solid tumor resections result in residual microscopic tumor cells at the surgical margin, which contributes to local recurrence and poor survival despite advancements in cancer therapies. Cold Atmospheric Plasma (CAP), a unique form of physical plasma, has...

Descripción completa

Detalles Bibliográficos
Autores principales: Canady, Jerome, Murthy, Saravana R. K., Zhuang, Taisen, Gitelis, Steven, Nissan, Aviram, Ly, Lawan, Jones, Olivia Z., Cheng, Xiaoqian, Adileh, Mohammad, Blank, Alan T., Colman, Matthew W., Millikan, Keith, O’Donoghue, Cristina, Stenson, Kerstin M., Ohara, Karen, Schtrechman, Gal, Keidar, Michael, Basadonna, Giacomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378184/
https://www.ncbi.nlm.nih.gov/pubmed/37509349
http://dx.doi.org/10.3390/cancers15143688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378184/
https://www.ncbi.nlm.nih.gov/pubmed/37509349
http://dx.doi.org/10.3390/cancers15143688

Ejemplares similares